Team

Peter Schulam, MD, PhD

Co-Founder

Dr. Peter Schulam is the inaugural chair of the Department of Urology at the Yale School of Medicine and co-founder of the Yale Center for Biomedical Innovation and Technology (CBIT). Dr. Schulam joins Yale from the Ronald Reagan Medical Center at the University of California at Los Angeles, where he was Vice Chair of Urology, Chief of the Division of Endourology and Minimally Invasive Surgery, and Director the Surgical Living Kidney Donor Program.

Dr. Schulam is a graduate of the NIH-funded Medical Scientist Training Program at Baylor College of Medicine and received his PhD in Immunology in 1990 and his MD in 1992. He then trained in Surgery as an intern and assistant resident from 1992-94 and in Urology as a resident from 1994-98 at Johns Hopkins Hospital.

Dr. Schulam has been very active in medical device development. He has been an advisor to Computer Motion, Intuitive Surgical, Karl Storz, ACMI and Cook. He is currently a scientific advisor to SurgiQuest, Suture Ease and MedicaMetrix. In addition, he holds the patent for the second-generation ureteroscope that is now the standard in urologic endoscopy.

While at UCLA, he founded the Center for Advanced Surgical and Interventional Technology (CASIT) for the development of next-generation surgical technology and for the enhancement of surgical education and training. It is because of this passion for improving patient care through the advancement of medical technology that he co-founded CBIT at Yale with Dr. Mark Saltzman.

Mark Saltzman, PhD

Co-Founder

Prof. Mark Saltzman is a co-founder of the Center for Biomedical Innovation and Technology (CBIT) at Yale, and is also the Chair of Biomedical Engineering, the Goizueta Foundation Professor of Biomedical Engineering, Chemical & Environmental Engineering, and Physiology. Dr. Saltzman has been recognized widely for his excellence in research and teaching. His work in drug delivery, biomaterials, nanobiotechnology, and tissue engineering have been described in over 250 research papers and patents. He is also the sole author of three textbooks: Biomedical Engineering (2009), Tissue Engineering (2004), and Drug Delivery (2001). 


Dr. Saltzman has received the Camille and Henry Dreyfus Foundation Teacher-Scholar Award (1990); the Allan C. Davis Medal as Maryland's Outstanding Young Engineer (1995); the Controlled Release Society Young Investigator Award (1996); and the Professional Progress in Engineering Award from Iowa State University (2000). He has been honored by election as a Fellow of the American Institute for Medical and Biological Engineering (1997); a Fellow of the Biomedical Engineering Society (2010); a Member of the Connecticut Academy of Science & Engineering (2012); and a Fellow of the National Academy of Inventors (2013). He has delivered over 200 invited lectures throughout the world including the Britton Chance Distinguished Lecture in Engineering and Medicine at the University of Pennsylvania (2000) and the Distinguished Lecture of the Biomedical Engineering Society (2004).

Chris Loose, PhD

Co-Executive Director

Dr. Loose serves as Executive Director of CBIT, while holding an appointment as Associate Professor Adjunct in Urology at Yale University. He is also an Accelerator Executive at the Center for Integration of Medicine and Innovative Technology (CIMIT).

In 2006, Dr. Loose co-founded Semprus BioSciences with Massachusetts Institute of Technology (MIT) Institute Professor Robert Langer and David Lucchino, and served as Chief Technology Officer until the company was acquired by Teleflex Incorporated in 2012 (TFX: $80M).  A peer-review of the Semprus Technology was published in Science Translational Medicine and received a Frost and Sullivan Breakthrough Technology Award in 2010.  Semprus’ first product, a vascular catheter with a surface modification designed to have reduced thrombus (clot) formation, was FDA-cleared in 2012.

Dr. Loose received the prestigious Hertz Foundation Fellowship and was selected by MIT’s Technology Review as a member of the “TR35,” naming the world's top 35 innovators under the age of 35. He was awarded the inaugural Peter Strauss Entrepreneurial Award from the Hertz Foundation in 2011 and was also named to Boston Business Journal's 40 emerging business leaders under 40.  

While earning his PhD. in Chemical Engineering at MIT, Dr. Loose co-authored the Semprus Biosciences business plan which won entrepreneurial competitions at MIT, Harvard University and Oxford University.  Prior to his graduate work, Dr. Loose was a chemical engineer at Merck Research Labs after graduating summa cum laude with a B.S.E in Chemical Engineering from Princeton University.

Mike Dempsey

Michael K. Dempsey

Co-Executive Director

Mike Dempsey has been working in the field of medical devices for more than 30 years; during this time he has invented or worked on products that have treated over twelve million people. Mike holds over 40 patents on various medical devices and has ten more patents pending. Mike is currently the founder and CEO of Secora.Care, an early-stage company that uses “Big Data” to help older people live safely at home as long as possible. 

Mike is also the Entrepreneur in Residence at the Center for the Integration of Medicine and Innovative Technology (CIMIT), the Director of the CIMIT Accelerator Program, the Co-Executive Director of the Center for Biomedical Innovation and Technology (CBIT) at Yale University, and a faculty member at MIT. Mike’s primary responsibilities in these academic settings are to lead academic innovators through the commercialization journey and to teach students the fundamentals of building medical companies. At CIMIT and Yale, Mike leads a team of highly experienced med-tech executives who join the academic team with up to a full-time commitment and for as long as two years, effectively acting as an interim CEO. This intensive, practical, and focused approach to facilitating the academic-to-commercial transition has led to a commercialization success rate of 42% and an average time to commercialize of 18 months. Mike is also the PI on several NIH SBIR grants, a frequent grant reviewer for the NIH, and has received a special citation from the Commissioner of the FDA for "exceptional initiative and leadership to protect the public health."

Ayesha Khalid

Ayesha Khalid, MD, MBA

Clinical Director

Ayesha is an Ear, Nose and Throat (ENT) surgeon at Harvard Medical School with over 10 years of experience in the healthcare industry. She is an endoscopic sinus surgeon and performed cutting edge basic science research at the University of Pennsylvania. She worked to set up the satellite practice for The Massachusetts  Eye and Ear Infirmary at Emerson Hospital in Concord, Massachusetts. Recently, Ayesha completed a fulltime mid-career MBA in Global Leadership and Innovation from the MIT Sloan School of Management.

Ayesha has combined her medical expertise and innovation experience to apply a systems thinking approach to solving healthcare problems as shown in her TedX talk. Ayesha joined MIT Hacking Medicine and has been helping to promote disruptive thinking in healthcare through organized events in Doha, Qatar, BIO 2014 and MIT. 

Ayesha has also served as a consultant at Lambay Advisors and worked with private equity firms on understanding market dynamics and business opportunities in the senior living space, health IT and the opportunities for practice management. As a practicing surgeon, Ayesha understands the healthcare change process and the need to foster cross-disciplinary engagement. Ayesha has served as the Vice-President of Business Development of a start-up focused on changing the surgical conversation with patients, Doctella. On a national level, Ayesha serves as an executive member on several Boards for medical organizations and is currently on the board of the American Academy of Otolaryngology- Head and Neck Surgery. 

Recently, Ayesha has joined the CBIT team at Yale to increase clinician engagement. Given that Ayesha bridges the gap between management and medicine, she is enthusiastic to support projects as they come through the CBIT ecosystem. She is currently co-teaching Creating Healthcare and Life Sciences Ventures with Dr. Loose at the Yale School of Management.


Margaret Cartiera

Margaret Cartiera, PhD

Investment and Innovation Director  

Dr. Margaret Cartiera serves as the Investment and Innovation Director at Yale’s Center for Biomedical Innovation and Technology, where she works in close collaboration with the YNHH Center for Health Innovation. She also supports the Tsai Center for Innovative Thinking at Yale as a Mentor in Residence.

Dr. Cartiera spent many years in industry in various roles in management, investment, business development, operations, and research. The experience gained working in different settings – from large healthcare companies, to pharma consulting firms, to biotech and digital health start-ups, to investment groups – have given her a distinct perspective on the innovation lifecycle, the multiple stakeholders involved, and current shifts in the healthcare landscape.

Prior to joining the team at Yale, Dr. Cartiera established and led Connecticut’s pioneering $200M 10-year bioscience innovation fund as vice president and fund manager. While leading operations in the start-up world, she successfully transferred technology from the academic setting, secured SBIR grants, built teams, and negotiated collaborative agreements with leading industry partners. Dr. Cartiera has worked with pharmaceutical executives at Fortune 500 companies in business development and competitive intelligence in the fields of oncology, CNS, anti-infectives, diabetes, and inflammation. She also has first-hand knowledge of the regulatory landscape and successful interaction with the FDA.  

Dr. Cartiera earned her Ph.D. in Biomedical Engineering from Yale University where her studies focused on polymer drug delivery systems. She completed a Master of Science degree from the University of Pennsylvania in Bioengineering, with business coursework at the Wharton School. Dr. Cartiera received her B.S. in Biomedical Engineering from Rensselaer Polytechnic Institute. 

David Rosenthal

David Rosenthal, MD

Clinical Advisor  

Dr. Rosenthal is a Primary Care Physician, Assistant Professor in the Section of General Internal Medicine at Yale Medical School, and the Medical Director of the Homeless Patient Aligned Care Team for VA Connecticut, a medical home model of care with specialized access for Veterans experiencing homelessness located in the Errera Community Care Center. His prior work experience spans roles in technology, education, and the arts – including helping to start a venture-backed health informatics startup keas.com after medical school. His documentary film entitled "Witnessing Death: A grandson's reflections on Alzheimer's" has been shown widely across the country and has been used in Certified Nursing Aide trainings. He has served previously as Tutor and Head Premedical Advisor at Pforzheimer House (Harvard), on various CT state Homelessness initiatives and workgroups including the Governor's Taskforce for Rocky Hill Redesign, the CT Heroes and Reaching Home Workgroup, and on clinical advisory boards for health startups.

Dr. Rosenthal also currently supports the Center for Biomedical Innovation and Technology and serves as the Course Director of the Capstone Course for all graduating Yale Medical Students. He helps teach courses in Professionalism and Ethical Responsibility, Patient Centered Interviewing, Physical Diagnosis, Biopsychosocial care, Clinical Reasoning, and others. He is a strong advocate for partnerships to focus on social determinants of health and vocal proponent of Medical-Legal Partnerships. Dr. Rosenthal graduated magna cum laude from Harvard College, received his M.D. from Feinberg School of Medicine, Northwestern University, and completed his internship and primary care residency at the Brigham and Women's Hospital in the Management and Leadership Track.

Administrative

Michelle Nantel - Operations and Program Manager